[Skip to Content]
[Skip to Content Landing]
Other Articles
March 6, 1937


Author Affiliations

Chicago. Associate in Pediatrics, Northwestern University Medical School.

JAMA. 1937;108(10):825. doi:10.1001/jama.1937.02780100055026

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  Dr. H. N. Cole in his article on "The Use of Antisyphilitic Remedies" (The Journal, Dec. 26, 1936) says: "As yet I am unwilling to recommend the indiscriminate use of acetarsone by mouth in the treatment of congenital syphilis. It is still too much in the experimental stage." This statement is emphatic and conclusive. It gives the reader the impression that acetarsone is of no value in the treatment of congenital syphilis.My experience with acetarsone, after using it for the last six years at the Northwestern University clinic, is different. I am of the opinion that acetarsone by mouth is the ideal drug for the treatment of congenital syphilis in the infant. In older children, it is true, neoarsphenamine with a bismuth compound or acetarsone with a bismuth compound is better.Although it is true that the use of acetarsone in this country has not been

First Page Preview View Large
First page PDF preview
First page PDF preview